Mu ntangiriro za 2026, urwego rw'ubuvuzi bw'indwara za kanseri mu Bushinwa rwageze ku ntambwe ikomeye. Ku ya 5 Mutarama, Ikigo cy'Igihugu gishinzwe Ubuvuzi mu Bushinwa (NMPA) cyemeje ku mugaragaro umuti mushya wa Repotrectinib wo kuvura abarwayi bakuru bafite ibibyimba bikomeye bifite imiterere ya neurotrophic tyrosine receptor kinase (NTRK). Uku kwemezwa kuzana icyizere gishya n'amahitamo ku barwayi benshi barwaye ibibyimba bikomeye bahura n'ibibazo byo kuvurwa, cyane cyane abananiwe uburyo bwo kuvurwa mbere cyangwa badafite uburyo bwo kuvura bufatika.
**Ibyerekeye Ocapler® (Repotrectinib): Umuti w’ikinyejana gishya, ukomeye kandi wibasiwe neza**
Ocapler® (Repotrectinib) ni umuti ugabanya ubukana bwa tyrosine kinase inhibitor (TKI) wo mu gisekuru gishya wagenewe kwibasira neza ihuriro rya ROS1 na NTRK oncogenic gene fusions. Ku barwayi bafite ibibyimba bikomeye (harimo na kanseri y'ibihaha itari nto, nibindi) bifite izi mpinduka mu ngirabuzimafatizo, Repotrectinib igaragaza akamaro kanini ndetse no nyuma yo kudakira imiti yagenewe mbere. Inagenzura neza metastases yo mu bwonko, itanga inyungu zirambye zo kuvura.
**Amakuru Ahamye Agaragaza Imikorere Idasanzwe**
Kwemezwa kwa NMPA gushingiye ku bushakashatsi bw’ingenzi bwakozwe ku rwego rw’isi mu cyiciro cya 1/2 cya TRIDENT-1. Ibisubizo birashimishije:
- **Ku barwayi bavuwe mbere hakoreshejwe uburyo bwa TRK:** Igipimo cy’ubutabazi bw’ibanze (ORR) cyageze kuri 50%, naho igipimo cyo kurwanya indwara (DCR) cya 42%.
- **Ku barwayi batazi uburyo bwo kuvura bataravurwa mbere hakoreshejwe uburyo bwa TRK:** Ingufu zirushaho kuba nyinshi, aho igipimo cy’ubutabazi bw’ibanze kigera kuri 58%, harimo igipimo cy’ubutabazi bwuzuye (CR) cya 15%, bivuze ko ibibyimba byashize burundu kuri bamwe mu barwayi. Ikigaragara ni uko 83% by’abasubije bakomeje kubyaza umusaruro nyuma y’umwaka umwe.
Aya makuru agaragaza neza ko Repotrectinib ikora neza kandi irambye mu kurwanya ikibyimba, hamwe n’umutekano wayo, ku barwayi bafite ibibyimba bikomeye bya NTRK fusion-positive.
**Ishami Mpuzamahanga ry'Ibitaro bya Oncology byo mu Karere k'Amajyepfo muri Beijing: Irembo ryawe ry'Ubuzima Mpuzamahanga**
Nk'imwe mu mavuriro akomeye mu Bushinwa asuzuma kandi akavura kanseri, Ishami Mpuzamahanga ry'Ibitaro bya Beijing mu Karere k'Amajyepfo rihora ku isonga mu kurwanya kanseri. Ishami Mpuzamahanga ry'Ubuvuzi ni ryo dirishya ryacu ryihariye ku barwayi baturutse impande zose z'isi, ryiyemeje gutanga serivisi z'ubuvuzi zinoze kandi zijyanye n'amahame mpuzamahanga.
**Kuki twahitamo?**
1. **Kubona Uburyo bwo Kuvura Bugezweho ku Isi:** Dukurikiranira hafi imiti iheruka kwemezwa ku isi (nk'uko Repotrectinib iherutse kwemezwa), tukareba ko abarwayi mpuzamahanga bashobora kubona uburyo bwo kuvura bugezweho mu Bushinwa bujyanye n'ubwo muri Leta Zunze Ubumwe za Amerika, i Burayi, n'ahandi.
2. **Itsinda ry’impuguke mu nzego zitandukanye (MDT):** Dufite itsinda ry’impuguke zifite uburambe mu nzego zitandukanye zikomeye zo kuvura kanseri, harimo kanseri y’ibihaha, sarcoma, na kanseri ya tiroyide, rishobora gutanga uburyo bwo gusuzuma neza no gutegura uburyo burambuye bwo kuvura abarwayi bafite imiterere idakunze kugaragara nka NTRK.
3. **Serivisi Mpuzamahanga z’Abarwayi:** Kuva ku nama y’ibanze, gusuzuma inyandiko z’abaganga, gahunda yo kubonana n’abaganga, n’inama z’abahanga kugeza ku gahunda yo kuvurwa, ubufasha bwo kujya mu bitaro, no gukurikirana ubuvuzi, dutanga serivisi nziza, zivuga indimi nyinshi, kandi zitabwaho mu gihe cyose cy’igikorwa.
4. **Guhuza ubuvuzi mu buryo bworoshye:** Dusobanukiwe neza ibyo abarwayi mpuzamahanga bakeneye mu ngendo no mu itumanaho kandi dushobora gutanga ubufasha bukenewe kugira ngo urugendo rwawe rw'ubuvuzi rugende neza kandi rutagira impungenge.
**Twandikire ubu kugira ngo utangire urugendo rwawe rwo kuvurwa neza**
Niba wowe cyangwa abakunzi bawe mushaka icyizere gishya cyo kuvura ibibyimba bikomeye bya NTRK fusion-positive, twandikire vuba. Itsinda ryacu ry’inzobere mu ishami ry’ubuvuzi mpuzamahanga ryiteguye gusuzuma niba ubifitiye uburenganzira no gutanga ubuyobozi burambuye ku buvuzi.
- **Umurongo Mpuzamahanga w'Abarwayi:** 400-880-3716
- **WeChat/WhatsApp:** +86 17801183037 (Indangamuntu ya WeChat: 17801183037)
- **Imeri:**
100085_010@163.com
myimmnet@163.com
*(Icyitonderwa: Kugira ngo itumanaho rirusheho gukora neza, mu gihe wohereza inyandiko z'ubuvuzi, andika aderesi zombi za imeri kandi ushyiremo ibisobanuro bigufi by'indwara.)*
**Inama y'Ibikorwa:**
Muzategure raporo z’indwara zijyanye n’uburwayi, raporo z’ibizamini by’uturemangingo (cyane cyane zirimo ibisubizo bya NTRK byo guhuza uturemangingo), hamwe n’inyandiko z’ubuvuzi bwakozwe mbere kugira ngo muduhe amakuru. Ibi bizafasha impuguke zacu gukora isuzuma ry’ibanze ryihuse kandi ryimbitse.
Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo rya Beijing ryiyemeje kurinda ubuzima n’ubuzima bw’abarwayi ku isi yose, rikoresheje ubuhanga mu by’ubuvuzi n’ubuvuzi bushyushye kandi burangwa n’impuhwe. Dutegereje igisubizo cyanyu ku bibazo byanyu.
Igihe cyo kohereza: Mutarama-08-2026